Talga Group

Phase A — Understand the business

Company Overview

Talga is a pre-revenue, development-stage vertically-integrated battery-anode company built on a single flagship asset: the Vittangi Anode Project in Norrbotten, northern Sweden. The model is "mine-to-anode" under one roof — mine natural flake graphite, concentrate it on site, then refine it in Luleå into a finished lithium-ion battery anode active material sold to cell makers. This is not a P&L-bearing operating company; it is a mining/materials project developer whose entire value is the option on Vittangi reaching commercial production. Analyze it as a single-asset project financing, not an earnings compounder.

The three physical pieces:

1. Nunasvaara South mine — Talga's 100%-owned graphite deposit, marketed as "the highest-grade natural graphite resource in the world." Planned output ~100,000 tpa of graphite ore concentrate on average.
2. Luleå Anode Refinery — converts concentrate into Talnode®-C, the finished natural-graphite anode. Stage-1 design 19,500 tpa of Talnode-C; the near-term commercial build has been de-scoped to a staged 5,000 tpa first line to shrink the FID cheque.
3. EVA demonstration plant (Luleå) — a 50 tpa test/qualification plant operating since 2022. This is where the only real revenue exists today and where customer qualification happens.

Products. Talnode-C (natural-graphite anode, the core product); Talnode®-R (a recycled-feedstock anode from Li-ion battery waste, the US-expansion vehicle); plus legacy graphene/coatings IP (Talcoat, graphene-concrete) that has generated headlines but essentially no revenue — a founder-era distraction (see Lens 9).

Customers / contract structure. The commercial pipeline is the thesis. Binding: Nyobolt (UK ultra-fast-charge battery developer) — a 3,000-tonne binding offtake, first commercial shipment already delivered from EVA. Non-binding: Verkor (French gigafactory, LOI, 4–8 yr supply), ACC / Automotive Cells Company (co-owned by Stellantis, Mercedes-Benz, Saft — non-binding offtake term sheet). Management states ~60% of initial capacity is covered by (mostly non-binding) offtakes, and reports 21 active qualification/validation programs running through EVA. Take-or-pay structure is not disclosed as binding at scale — the offtakes are conditional letters, not bankable contracts, which is precisely the FID bottleneck (Lens 5/11).

Where it makes money (eventually). Sell finished anode into European (and later US/Japan) cell makers at a "green premium" to Chinese synthetic/natural anode. The DFS pencils ~A$200m+ peak annual revenue at full 19,500 tpa. Today: A$57k of anode revenue in Q3 FY2026 from the test plant. The gap between those two numbers is the investment.

Supply Chain

Map the physical chain, every named node:

Upstream (into Talga):

• Ore — Talga's own Nunasvaara South deposit (100%-owned; no third-party feed dependency for Talnode-C — a genuine structural advantage vs peers who buy concentrate). For Talnode-R, feedstock = recycled Li-ion black mass, sourced via US recycling partners (unnamed strategic agreements).
• Engineering / EPCM — Worley is the engineering partner on the Vittangi build (~$150m EPCM scope).
• Energy — Swedish grid (fossil-free hydro/nuclear), the basis of the "net-zero anode" pitch; FEED claims a 23% energy-efficiency saving vs base plan. Cheap Nordic clean power is the single biggest cost lever against China.

Midstream (Talga itself): Nunasvaara mine → on-site concentrator → Luleå refinery (sphericalization, purification, coating) → Talnode-C. Vertical integration mine-to-anode is rare outside China and is the core differentiator.

Downstream (out of Talga):

• Nyobolt (binding, UK) — fast-charge cells.
• Verkor (LOI, France) — EVEnterprise valueWhat it would cost to buy the whole company: its market value plus its debt, minus the cash you would get with it. Often very different from market cap. gigafactory.
• ACC / Automotive Cells Company (Stellantis + Mercedes + Saft) — EV cells.
• 21 unnamed qualification-stage cell makers via EVA.
• Ultimate demand: European gigafactory buildout (planned EU capacity 191→1,160 GWh 2024→2030).

Chokepoints / single-source dependencies:

1. Demand-side single point of failure — the entire offtake book depends on European cell makers actually reaching volume. Northvolt's bankruptcy (US Chapter 11 Nov 2024 → Swedish bankruptcy Mar 2025) removed the flagship European anchor customer and is a live warning that EU gigafactory demand is softer than the 1,160 GWh headline implies. Talga's offtakes are all non-Northvolt, but the read-through to the whole EU battery thesis is negative.
2. Capital as the chokepoint — the refinery cannot be built without ~€600m of project finance Talga does not have (Lens 5/11). The physical chain is de-risked (permits done); the financial chain is not.
3. Chinese input independence is a genuine strength — because Talga mines its own graphite in Sweden and refines with Nordic clean power, it is one of very few anode routes with zero Chinese feedstock or processing exposure, exactly the ex-China supply the EU CRMA wants.

This lens does NOT fail on generality — the nodes are named. But note the chain is a blueprint, not an operating flow: nothing moves at commercial scale yet.

Competitive Advantages (moats)

Real, durable moats:

1. Resource quality + 100% ownership. Nunasvaara is marketed as the world's highest-grade natural graphite; owning the mine end-to-end removes the concentrate-purchasing margin leak that hobbles competitors. High grade → lower unit cost → the only credible cost defense against Chinese synthetic anode.
2. Permitting moat (the scarcest asset in Europe). In late 2024 the Swedish Supreme Court upheld the environmental/Natura 2000 permit for Nunasvaara South, exhausting the statutory appeals process. In a jurisdiction where permitting takes a decade and kills most projects, a fully-permitted, EU-strategic graphite mine is close to un-replicable on any near-term horizon. This is Talga's single strongest moat.
3. EU strategic designation. Vittangi/Luleå carry Strategic Project status under both the Critical Raw Materials Act and the Net-Zero Industry Act, and the Luleå refinery is an EU-recognized net-zero strategic project. This unlocks a €70m EU Innovation Fund grant and an approved €150m EIB senior debt facility — non-dilutive capital access peers can't match.
4. Green/low-carbon differentiation. Fossil-free Nordic power gives Talnode-C a genuine carbon-footprint edge, which matters for EU-CBAM-exposed and ESG-scored automotive buyers.

Weak / contested moats:

• Product/technology moat is unproven at scale. Talnode-C works in a 50 tpa demo and 21 qualification programs, but graphite anode is not a patent-defensible product category — it's a commodity active material where the low-cost producer (China) wins. The moat is cost + provenance + location, not IP.
• Bargaining power is weak today. A pre-revenue developer negotiating with Stellantis-scale buyers has little leverage — which is why the offtakes are non-binding LOIs, not take-or-pay. Talga needs the buyers more than they need Talga while China floods the market at 50–70% below peak.

Net: the moat is permits + resource + EU backing + clean power — genuinely hard to replicate — wrapped around a commodity product with no pricing power and no balance sheet. A strong castle with no water in the moat yet.

Segments

Talga is effectively single-segment, single-asset, pre-revenue — there is no meaningful revenue to break out. our figures is empty. What exists:

• Battery Materials (Talnode-C / -R) — 100% of the forward thesis; today ~A$57k/quarter of test-plant sales.
• Graphene / advanced materials (Talcoat, graphene-concrete) — legacy, immaterial revenue, effectively deprioritized under CEO Phillips.
• Geography — all operations in Sweden; corporate in Perth, Australia; expansion offices/plans in US, UK, Germany.

Revenue by segment/geography, EBITDA, and earnings splits are n/a — pre-revenue, not sourced. The only "trend" that matters: revenue is a rounding error and stays that way until FID + first commercial production (targeted 2027–28). There is nothing to decelerate — the question is binary (does the plant get built), not marginal.

---

Phase B — Measure performance

Earnings Result (latest — Q3 FY2026, quarter to ~Mar 2026)

There are no "earnings" — read this as a cash-burn and funding-runway print:

• Cash at quarter-end: A$28.2m, of which A$10.4m is restricted grant funds → ~A$17.8m unrestricted.
• Operating cash burn: A$4.2m in Q3; capex A$2.0m → ~A$6.2m total quarterly outflow.
• Anode revenue: A$57k (EVA 50 tpa plant); H2 FY2025 total revenue A$518k (anode + interest + grant income).
• Runway (pre-FID, at current burn): ~3–4 quarters of unrestricted cash. This is the single most important number in the dossier — Talga is a perennial capital-raiser and will need equity again before FID regardless of the EIB/EU packages.

Funding secured vs. required:

• Secured (mostly conditional/undrawn): €150m EIB senior debt (undrawn, subject to final negotiation), €70m EU Innovation Fund grant, SEK 82.6m (~A$13.35m) Industriklivet-1 grant.
• Required: the 2024 FEED puts full Stage-1 capex at ~€560m + €39m contingency ≈ €599m (vs the 2021 DFS estimate of US$595.8m ). Debt gearing targeted at ~60%, implying ~€200m+ of equity/other still to raise.
• The gap is existential: ~€200m of equity needed against a ~A$148m total market cap. Absent a strategic or sovereign equity partner, funding Stage-1 in full means >100% dilution at today's price. This is why the near-term plan has quietly shrunk to a staged 5,000 tpa first line — a smaller cheque Talga might actually close.

Balance-sheet flags: minimal debt drawn (good), but chronic negative operating cash flow, near-zero revenue, and a capitalized-development balance sheet whose value is entirely contingent on FID. Going-concern / funding-gap language is the standard "no guarantee financing negotiations conclude" disclosure attached to the EIB facility.

Market reaction / where it's priced: the stock sits near multi-year lows (~A$0.28), i.e. the market is pricing substantial dilution and FID risk, not the DFS NPV. Good news (permit win, EIB approval, first shipment) has repeatedly failed to hold the price because each is overshadowed by the equity-raise overhang.

Earnings Calls / management commentary (sentiment trend)

No earnings-call transcripts exist on the research layer (transcripts/ empty) and ASX small-caps don't run US-style quarterly calls; sentiment is read from quarterly activity reports + ASX releases + interviews:

• 2021–22 (peak): euphoric — "world's highest-grade graphite," graphene-concrete moonshots, share price to A$2.23 (Nov 2021). Founder-CEO Mark Thompson's promotional register.
• 2023–24 (grind): tone shifts to permitting-and-patience — repeated "arduous Swedish approvals process," 18-month construction slips to ~2 years behind schedule. The story becomes "when, not if."
• 2025–26 (de-risk-and-fund): under CEO Marty Phillips, language is disciplined and milestone-driven — "FEED complete," "record customer validation," "21 active qualification programs," "pathway to FID," "non-dilutive funding." The recurring new phrase is "staged" / "5,000 tpa" ramp — an implicit admission that the full 19,500 tpa is not fundable in one step. What they've stopped saying: the aggressive first-production dates (originally 2023, then 2025, now 2027–28) and the graphene side-stories.

Sentiment verdict: management tone has matured from promotional to executional, which is appropriate but also reflects a market that stopped rewarding narrative. The honest tell is the quiet de-scoping — credibility on timelines is impaired by a multi-year slippage history.

Comps

Peer set = ex-China graphite/anode developers (from _index.json critical-materials, filtered to graphite/anode). Standard operating-comp multiples (EV/Sales, P/E) are meaningless here — the entire cohort is pre-/early-revenue and loss-making, so the comparison is by stage, market cap, funding, and asset:

P/E, EV/EBITDA, EV/Sales, dividend yield, 5-yr avg ROE for all names: n/a (and not meaningful — pre-earnings cohort).

Read-through: the whole ex-China graphite-developer complex is in a funding winter — Syrah has idled Balama, NMG trades at a fraction of its highs, Novonix was hit by the ITC ruling. Talga is not an outlier struggling in isolation; it's the median of a sector the market has left for dead while Chinese oversupply persists. On a NAV/NPV basis, sponsored research (Zacks/Thomas Kerr) pegs Talga at US$1.50 PT (DCF US$1.71 @15%; 11.9× FY28 P/Rev = US$1.03) vs a share price near US$0.18 — i.e. trading at a ~70–90% discount to modeled NAV. That discount is the market's probability weight on (a) FID never closing and (b) the dilution to get there. Treat the US$1.50 as a fully-funded, fully-executed number, not a base case.

Stock-Price Catalysts (what actually moves TLG >5%)

Pattern over ~5 years:

• All-time high A$2.23 — 9 Nov 2021, on graphite/EV-supply-chain euphoria + graphene hype.
• 2022–24 grind down on: repeated permit delays (the dominant driver), the Swedish approvals saga, and rolling capital raises (each placement/SPP = a leg down).
• Permit wins (environmental permit in force Oct 2024; Supreme Court appeal dismissed) produced relief rallies that faded — the market treated permits as necessary-not-sufficient because funding remained open.
• EIB €150m approval + first Nyobolt shipment (2025) — positive but muted, again swamped by dilution overhang.
• 2026 macro hits: US ITC negative determination (12 Mar 2026) blocking Chinese-graphite tariffs, and China suspending export controls to the US to 27 Nov 2026, both undercut the ex-China scarcity trade. Northvolt bankruptcy hangs over EU demand.
• 52-week range A$0.19–0.565, last ~A$0.28 (3 Jul 2026).

What the market actually reacts to for this name: (1) funding events (raises down, a strategic/sovereign backstop would be up big), (2) permit/legal milestones, (3) FID timing signals, and (4) China policy / graphite price as the sector beta. It does not meaningfully react to graphene side-projects or qualification headlines anymore. FID + a named cornerstone equity investor is the one catalyst that re-rates the stock.

---

Phase C — Judge people & books

Management

• Marty (Martin) Phillips — Group CEO since Feb 2024. 25+ years in global metals & mining, project/commercial manager and company director. Brought in explicitly to professionalize execution and drive to FID/financing — the right archetype for the stage (a builder/financier, not a promoter). Track record at Talga is still short (~2.3 yrs) and unproven on the one thing that matters (closing FID).
• Mark Thompson — Founder & Managing Director (strategic/non-operational). 35+ yrs geoscience; previously founded ASX-listed Catalyst Metals; led Talga's 2011 pivot from gold exploration into Swedish graphite and the graphene technology story. Founder archetype: promotional geologist-discoverer. Strengths: found and secured a genuinely world-class deposit, navigated a decade of Swedish permitting. Weaknesses: the graphene-concrete / Talcoat side-quests consumed attention and capital for years with no monetization — a capital-allocation and focus red flag. His transition out of the CEO seat into an MD/strategic role (with Phillips taking operations) reads as the board correctly narrowing him to what he's good at. Retains ~9% of shares — meaningful skin in the game and alignment.
• Eva Nordmark — Chair, Talga AB (Sweden), from 1 Jul 2024. Former Swedish Minister of Employment. A shrewd political appointment — Sweden/EU government funding and social license are gating variables, and a former minister as Swedish chair is a deliberate lobbying/relationship asset.
• Per-Inge Kruse — Group Director, Business Development & Strategic Alliances (20+ yrs automotive sales/BD) — hired to convert the qualification pipeline into binding offtakes.

Capital-allocation history: mixed. Positive — secured a world-class asset, exhausted permitting, won substantial EU non-dilutive grants/debt. Negative — years and dollars sunk into non-core graphene ventures, and a long trail of dilutive equity raises (most recently A$14.5m placement + A$7.3m SPP at A$0.41, Mar 2026) that have crushed per-share value from the A$2.23 peak. ROE/ROIC are negative — pre-revenue, n/a.

Red flags: (1) chronic dilution and a promotional founder legacy; (2) repeated timeline slippage (first production 2023→2025→2027–28); (3) offtakes stuck at non-binding after years. No related-party or governance scandal surfaced. Net: the upgrade to Phillips + Nordmark is the most bullish governance signal; the founder's side-project history is the most cautionary.

Forensic Red Flags

Accounting risk (pre-revenue developer): the balance sheet is dominated by capitalized exploration & development assets whose carrying value is entirely contingent on FID — a classic impairment risk if funding fails or graphite prices stay depressed. With near-zero revenue there is no revenue-recognition or receivables-vs-revenue divergence to police; the forensic question is capitalization vs. write-off and going-concern. Cash flow diverges from "earnings" only in the trivial sense that both are negative. Watch: grant income and R&D tax treatment flattering the P&L, and SBC dilution (500k performance rights + 41.3m options outstanding). All figures — no audited research-layer data on file.

Regulatory findings (required sub-section):

• SEC (EDGAR LR/AAER): — Talga has no CIK and is not an SEC filer; zero SEC enforcement findings possible. Total SEC findings: 0.
• Non-SEC enforcement (web search — FTC/DOJ/FDA/consent-decree/penalty): no financial-regulatory enforcement action found against Talga Group as of 2026-07-07.
• Material legal / social-license exposure (the real "Item 3"): the live issue is not accounting fraud but ESG/Indigenous-rights conflict. Nunasvaara South sits on winter grazing land used by Sámi reindeer herders, who have protested the EU-backed mine; a 2019 Talma-community reindeer-husbandry analysis concluded mining and herding cannot coexist on the site, and NGOs argue the CRMA "strategic project" fast-track (27-month permitting) bypassed full free-prior-and-informed-consent. The permit survived Supreme Court appeal, so it is legally settled — but the reputational/relationship risk with an Indigenous community and European ESG-scored automakers is real and ongoing.
• Verdict: No material financial-regulatory or securities findings — verified via SEC EDGAR EFTS (no CIK), web enforcement search, and public disclosure as of 2026-07-07. The material risk is social-license/ESG (Sámi land rights), which is legally cleared but reputationally live.

---

Phase D — Project & stress-test

Forward Projection (development-stage: rNAV / runway-to-FID, not EPS)

An EPS projection is meaningless for a pre-revenue single-asset developer — the right frame is rNAV-to-FID and runway, per the mining variant of the battery.

Project economics (source figures):

• 2021 DFS: pre-tax NPV US$1,054m @8%, IRR 30%, payback 2.5 yrs, capex US$595.8m, 24-yr LOM, LOM revenue US$5,352m.
• 2024 FEED: Stage-1 capex €560m + €39m contingency (€599m), 23% energy saving.
• Sponsored-research valuation: US$1.50 PT (DCF US$1.71 @15%).

Three scenarios (all, fully-diluted, judgment-weighted):

• BEAR (~45% weight): No cornerstone equity partner materializes at a fundable price; graphite stays depressed (China oversupply + ITC no-tariff + export-control suspension); Talga either stalls at the 5,000 tpa demo-scale line funded by grants + heavy dilution, or raises ~€200m equity at/below current price → >100% dilution, per-share NAV craters. Downside: A$0.10–0.15 (further dilution + sentiment).
• BASE (~40% weight): Talga closes a staged 5,000 tpa FID in 2026–27 using EIB debt + EU grants + a modest strategic/ECA equity slug + more dilution; first commercial output 2027–28; the full 19,500 tpa is deferred. Stock re-rates on FID certainty but the dilution caps upside. A$0.35–0.60.
• BULL (~15% weight): A strategic or sovereign cornerstone (automaker, EU/Swedish/Australian government vehicle, or a Japanese/Korean trading house) takes equity at a premium, de-risking funding without catastrophic dilution; China policy tightens again post-Nov-2026; graphite prices recover. Stock moves toward the sponsored A$1.00–1.50 NAV.

The one question that decides everything: Does Talga secure equity funding for FID before the cash runway forces another down-round? Runway is ~3–4 quarters of unrestricted cash; the EIB/EU packages are conditional on that equity. This is a binary funding call dressed up as a mining project.

Brier forecast: not logged. Per --watchlist rules, our model create is skipped in the sweep (no committed base case from a human). If promoted to a thesis, the tracked forecast should be a binary: "Talga announces FID on the Vittangi/Luleå anode plant by 31 Dec 2027 — p≈0.45", resolved on the FID announcement, not an EPS line.

Bull vs Bear

Bull case. Talga owns the two scarcest things in the European battery supply chain: a fully-permitted, world-class-grade graphite mine and an EU-strategic, clean-powered anode refinery — an asset combination that is close to un-replicable given Swedish permitting timelines. The EU needs ex-China anode (CRMA/NZIA), is paying for it (€70m grant, €150m EIB, national grants), and Talnode-C is already shipping commercially with 21 live qualification programs. If even the staged 5,000 tpa line gets funded, Talga becomes Europe's first integrated mine-to-anode producer with first-mover offtake relationships (Verkor, ACC/Stellantis-Mercedes) and a green premium. Sponsored NAV of ~US$1.50 vs an ~US$0.18 price implies a 3–8× re-rate on execution. The contrarian read: the market has thrown out the entire ex-China graphite cohort at the exact moment Western policy is structurally reshoring the supply chain — Talga is the best-permitted call option on that reversal.

Bear case (2–3 permanent-impairment risks).

1. Un-fundable at this price. ~€200m+ equity gap against a ~A$148m market cap: absent a cornerstone, funding Stage-1 means dilution that permanently caps per-share value — or the plant simply never gets built and the capitalized asset is impaired to near-zero. Funding risk is the thesis.
2. The ex-China thesis just cracked. The US ITC negative determination (Mar 2026) blocked the Chinese-graphite tariffs, and China suspended export controls to the US to Nov 2026 — both remove the scarcity/price umbrella Western developers were counting on. Graphite is 50–70% below its 2022 peak with Chinese oversupply persisting; Syrah has idled Balama. If prices don't recover, the DFS NPV is fiction.
3. Demand hollowing out. Northvolt's bankruptcy shows EU gigafactory demand is far softer than the 1,160 GWh headline; Talga's offtakes are non-binding and could evaporate if European cell-making stalls or Asian majors (LG, CATL) supply Europe from their own integrated chains.

Pre-mortem (18 months out, thesis broke): It's early 2028. Talga raised €150–200m equity in a deeply dilutive placement to satisfy EIB conditions, share count doubled, and graphite prices never recovered because China kept the taps open post-November-2026. The staged 5,000 tpa line is behind schedule and running below nameplate; one non-binding offtake (Verkor/ACC) lapsed as a European gigafactory pushed out its timeline. The stock is at A$0.10. The permits and the mine are still world-class — but the equity holders were wiped out funding the gap.

Are multiples too high? There are no earnings multiples; on NAV the stock trades at a deep discount, which is rational given funding/dilution risk — it is not an overvalued name, it is a binary, cheaply-priced option where the discount is the market's honest probability weight on failure.

Contrarian view (what the market refuses to see): the market is pricing Talga as if permits + EU backing are worthless because funding is hard — but a single strategic/sovereign cornerstone cheque flips the entire risk profile overnight, and the political will (EU industrial sovereignty, Swedish jobs, a former minister as chair) to make that cheque appear is being underweighted. The asymmetry is real; the timing is unknowable.

Devil's Advocate (short-seller)

Dismantling the bull case. What structurally breaks Talga's economics: it is a price-taker in a commodity (anode) whose price is set by a Chinese oligopoly running structural oversupply, and it cannot fund its own plant. Revenue is concentrated in offtakes that are non-binding LOIs — if Verkor/ACC slip or walk (entirely plausible post-Northvolt, as European cell-making disappoints), the "60% covered" number is marketing, not backlog. The moat bulls cite (permits) is necessary but not sufficient — a permitted mine you can't finance is a stranded asset. The most dangerous competitor bulls underestimate isn't another junior — it's China itself, which just got its US tariffs rejected by the ITC and can flood Europe with sub-cost anode indefinitely, plus integrated Asian cell makers (LG, CATL) who bring their own graphite and don't need Talga.

The worst capital-allocation history: years of graphene side-projects that monetized nothing and a serial-dilution track record that has destroyed ~88% of peak equity value. Management incentives include 41.3m options + performance rights that dilute further. For today's ~A$0.28 to hold, you must assume FID closes and graphite recovers and dilution stays modest — three things that must all go right. If growth/pricing disappoints by 20–30%, the DFS NPV (already at an 8% rate that looks generous for a single-asset pre-production junior) collapses — at a 15% discount the DCF is US$1.71, but haircut peak-sales realization by 25% and add the dilution and it's a low-single-digit-cents intrinsic value. The single scenario that permanently impairs the business: the equity raise fails or is catastrophically dilutive, the plant is deferred indefinitely, and the capitalized development asset is written down — plausibility: moderate-to-high given the runway and the market cap. A credible bear price target is A$0.10–0.15.

Management Questions (ordered by information value)

1. Exactly how much equity must Talga raise to reach FID on the staged 5,000 tpa line vs. the full 19,500 tpa, and at what share price / structure — and is a named cornerstone (strategic or sovereign) in active negotiation? (This single answer decides the stock.)
2. What are the precise conditions precedent on the €150m EIB facility and the €70m EU Innovation Fund grant, and which remain unmet today?
3. Which of the offtakes (Verkor, ACC) are on a defined path to binding take-or-pay, and what volume/tenor/price terms — and what happens to your financing case if one lapses?
4. Post-Northvolt bankruptcy, what is your current view of firm European gigafactory demand for Talnode-C over 2027–2030, and how much of your offtake book is exposed to at-risk projects?
5. Given the US ITC no-tariff ruling and China's export-control suspension, what graphite/anode price deck underpins your economics, and what is the NPV at spot prices (not DFS assumptions)?
6. What is the current unrestricted cash runway in quarters, and at what point does it force another raise irrespective of FID timing?
7. Why has the commercial plan de-scoped from 19,500 to 5,000 tpa, and does that materially change project-level unit economics and IRR?
8. What is your all-in unit cost (US$/tonne) for Talnode-C at 5,000 tpa vs 19,500 tpa, and how does it compare to landed Chinese synthetic/natural anode in Europe after CBAM?
9. What is the realistic FID date you would stake credibility on, and what are the top three things that could push it beyond 2027?
10. How are you managing the Sámi reindeer-herder relationship and ESG exposure — is there a co-existence/benefit agreement, and could social-license issues affect EU funding or automaker offtakes?
11. What is the status and revenue potential of Talnode-R (recycled) and the US expansion — is it a genuine second leg or an optionality story?
12. How much has been capitalized on the balance sheet for Vittangi/Luleå, and under what scenario would it be impaired?
13. What role do Swedish and Australian export credit agencies play in the debt stack, and are those facilities committed?
14. What is the board's dilution philosophy — is there a floor price below which you would defer the project rather than raise?
15. If China permanently out-competes on anode price, what is Talga's defensible niche (fast-charge / high-power / green-premium segments) and how large is that addressable slice vs the mass EV market?

---